Fortress Biotech Inc. operates as a biopharmaceutical company involved in the development and commercialization of novel pharmaceutical and biotechnology products. Its primary function is to nurture and advance a diverse portfolio of potential new treatments for rare diseases, cancer, and other serious health conditions. A distinctive feature of Fortress Biotech is its innovative partnership model; it acquires, develops, and commercializes these therapies through multiple subsidiary companies and licensing agreements. This structure allows for specialized focus and flexibility in progressing early-stage drug candidates. Fortress Biotech significantly impacts the healthcare sector, particularly in areas of unmet medical needs where it seeks to bring breakthrough therapies to market. By creating a platform for research and development across its subsidiaries, the company plays a crucial role in fostering advancements in medical treatments and addressing critical gaps within pharmaceutical innovation and patient care.